Cryofocus Medtech (Shanghai) Co., Ltd. (HKG:6922)

HKG:6922 Revenue

Cryofocus Medtech (Shanghai) had revenue of 40.68M CNY in the half year ending June 30, 2026, with 108.88% growth. This brings the company's revenue in the last twelve months to 84.84M, down -0.38% year-over-year. In the year 2025, Cryofocus Medtech (Shanghai) had annual revenue of 95.27M with 77.97% growth.

• Revenue (ttm): 84.84M CNY
• Revenue Growth: -0.38%
• P/S Ratio: 6.66
• Revenue / Employee: 493.26K CNY
• Employees: 172
• Market Cap: 652.14M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	95.27M	41.74M	77.97%
Dec 31, 2024	53.53M	12.58M	30.72%
Dec 31, 2023	40.95M	13.80M	50.83%
Dec 31, 2022	27.15M	4.72M	21.06%
Dec 31, 2021	22.43M	13.37M	147.69%

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 13, 2026

Data Sources Report a data error